Synapse

← European Heart Journal - Quality of Care and Clinical Outcomes

Papers in European Heart Journal - Quality of Care and Clinical Outcomes

Page 2 · newest first

  1. Affordability of Innovation –Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Health-care SystemEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  2. Comparison of different long-term cardiovascular disease risk prediction horizons to guide preventive drug treatment in apparently healthy individualsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  3. More from less: the case of non-invasive imaging in angina with non-obstructive coronary artery diseaseEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  4. Potential Bias in Efficacy Estimates Due to Intercurrent Treatment DiscontinuationsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  5. Italy passes obesity law: an opportunity to prevent cardiovascular disease across EuropeEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  6. Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  7. The Yentl syndrome revisited: under-diagnosis and under-treatment in women with wild-type amyloid transthyretin cardiomyopathyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  8. Heart failure guideline-directed medical therapy in young adults with dystrophin-related cardiomyopathy: the HOPE-MD registryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  9. Air Travel in Patients with Acute Coronary Syndromes or Heart Failure: Current Evidence, Guidance and GapsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  10. Biomarkers and Prognosis After Myocardial Infarction: Towards Precision CardiologyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  11. Cardiovascular and Renal Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  12. Response to the correspondence ‘From composite events to clinical action: disentangling arrhythmia risk in a new Fabry CMR prognostic score’European Heart Journal - Quality of Care and Clinical Outcomes · 2026
  13. Patient–physician sex concordance in cardiovascular care: context mattersEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  14. Atrial fibrillation and Risk of Myocardial Infarction in women and men: similar, yet so differentEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  15. End-of-life management in patients with implantable cardioverter-defibrillators: a core responsibility throughout the cardiology pathwayEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  16. Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigmEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  17. Natriuretic peptides—a screening tool for heart failure?European Heart Journal - Quality of Care and Clinical Outcomes · 2026
  18. Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort studyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  19. Advanced maternal age at first delivery as a risk factor for long-term cardiovascular diseaseEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  20. Clinical and Economic Outcomes Following First-Time Myocardial Infarction: A Nationwide Cohort Study from the SWEDEHEART RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  21. Atrial fibrillation and risk of myocardial infarction by sex and time since diagnosis. The Tromsø Study 1994–2021European Heart Journal - Quality of Care and Clinical Outcomes · 2026
  22. Diagnostic validation and prognostic implications of serial 0/1/3h stratification in patients with suspected myocardial infarction using high-sensitivity troponin TEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  23. Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  24. Regional and Socioeconomic Disparities in the Diagnosis of Primary Electrical Diseases in a Universal Healthcare System: A Nationwide Danish StudyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  25. Anti-Obesity Medications in Adults with Congenital Heart Disease: A Comprehensive Review and Expert Clinical RecommendationsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  26. Physician–Patient Sex Dyads and Management of Dyslipidaemia and Hypertension in Primary Care: Findings from Two Population-Based StudiesEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  27. Sex Differences in Coronary Disease Health Status Outcomes: the ISCHEMIA TrialEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  28. Evidence saves lives only when it is implementedEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  29. Between evidence and ambiguity: reassessing HFrEF guidelinesEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  30. Sodium-glucose cotransporter 2 inhibitors across cardio-reno-metabolic disease and body mass index: a meta-analysis of randomized controlled trialsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  31. Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementationEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  32. Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiographyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  33. Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trialEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  34. Risk charts are not neutral: reconsidering threshold effects in SCORE2-based treatment eligibilityEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  35. Mind the missed-fibrinolysis gapEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  36. Association of GLP-1 Receptor Agonists Versus Bariatric Surgery with Outcomes in Obese Patients with Hypertrophic Cardiomyopathy: A Multicenter Propensity-Matched AnalysisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  37. Correction to: Optimizing patient triage on the waiting list for transcatheter aortic valve replacement: the clinical utility of the cardiac damage staging systemEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  38. Association of lipoprotein(a) level and major adverse cardiovascular events in adult cancer survivors with atherosclerotic diseaseEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  39. Heart failure outcomes in a virtually run hospital-at-home settingEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  40. Evaluating TAVI quality indicators: critical insights from the SWEDEHEART experience and future directionsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  41. Rethinking TAVR triage: not only who, but whenEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  42. Implementation of quality of care in heart failure and in predisposing conditionsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  43. Socioeconomic deprivation and post-discharge mortality in heart failure: evidence from a nationwide universal health coverage systemEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  44. Pharmacological treatment after a first myocardial infarction in Sweden—long-term adherence and prognosisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  45. Mental disorders, mortality following myocardial infarction and the impact of the COVID-19 pandemic in England: a cohort studyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  46. Missed Opportunity for Fibrinolysis in ST-Segment–Elevation Myocardial Infarction: The Nationwide France-PCI RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  47. Method Validation of Cardiopulmonary Exercise Testing: Intra- and Inter-Device Comparisons Across Four Metabolic CartsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  48. Shifting Paradigms in ICD Tachytherapy Deactivation in the Final Phase of Life: Eighteen Years of PerspectiveEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  49. Integrating genetic and imaging information to enhance cardiovascular risk stratification: rationale and design of the CVRISK-IT randomised controlled trialEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026
  50. Heart failure with reduced ejection fraction: A systematic review of clinical practice guidelines and recommendationsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2026